In particular, sporadic cases of autoimmune hepatitis (AIH) have been described in untreated MS patients or following treatment with interferon-beta or other immunomodulatory therapeutic agents, including steroids and glatiramer acetate [9]. This evidence concerns the gene IFNB1 and myeloid sarcoma.